Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Angelini

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
International Journal of Molecular Sciences|April 14, 2016
Toward Precision Medicine: How Far Is the Goal?Gloria Ravegnini, Sabrina Angelini
Mutagenesis|March 7, 2003
Simultaneous detection of the exon 10 polymorphism and a novel intronic single base insertion polymorphism in the XPD gene using single strand conformation polymorphismRajiv Kumar, Sabrina Angelini, Kari Hemminki
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Somatic pharmacogenomics of gastrointestinal stromal tumorGloria Ravegnini, Patrizia Hrelia, Sabrina Angelini
Oncogene|December 19, 2003
Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9Rajiv Kumar, Sabrina Angelini, Kari Hemminki
The Journal of Investigative Dermatology|March 11, 2004
BRAF mutations are common somatic events in melanocytic neviRajiv Kumar, Sabrina Angelini, Erna Snellman, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 27, 2015
Key Genetic and Epigenetic Mechanisms in Chemical CarcinogenesisGloria Ravegnini, Gulia Sammarini, Patrizia Hrelia, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 6, 2016
Pharmacogenetics of tyrosine kinase inhibitors in gastrointestinal stromal tumor and chronic myeloid leukemiaGloria Ravegnini, Giulia Sammarini, Sabrina Angelini, et al.
Toxicology Letters|April 20, 2004
A molecular epidemiological approach to health risk assessment of urban air pollutionPatrizia Hrelia, Francesca Maffei, Sabrina Angelini, et al.
Pharmacological Research|February 11, 2018
Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysisSarah Cargnin, Gloria Ravegnini, Simona Soverini, et al.
Pharmacogenomics|June 11, 2013
Clinical relevance of pharmacogenetics in gastrointestinal stromal tumor treatment in the era of personalized therapySabrina Angelini, Gloria Ravegnini, Jonathan A Fletcher, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
International Journal of Molecular Sciences|April 14, 2016
Toward Precision Medicine: How Far Is the Goal?Gloria Ravegnini, Sabrina Angelini
Mutagenesis|March 7, 2003
Simultaneous detection of the exon 10 polymorphism and a novel intronic single base insertion polymorphism in the XPD gene using single strand conformation polymorphismRajiv Kumar, Sabrina Angelini, Kari Hemminki
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Somatic pharmacogenomics of gastrointestinal stromal tumorGloria Ravegnini, Patrizia Hrelia, Sabrina Angelini
Oncogene|December 19, 2003
Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9Rajiv Kumar, Sabrina Angelini, Kari Hemminki
The Journal of Investigative Dermatology|March 11, 2004
BRAF mutations are common somatic events in melanocytic neviRajiv Kumar, Sabrina Angelini, Erna Snellman, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 27, 2015
Key Genetic and Epigenetic Mechanisms in Chemical CarcinogenesisGloria Ravegnini, Gulia Sammarini, Patrizia Hrelia, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 6, 2016
Pharmacogenetics of tyrosine kinase inhibitors in gastrointestinal stromal tumor and chronic myeloid leukemiaGloria Ravegnini, Giulia Sammarini, Sabrina Angelini, et al.
Toxicology Letters|April 20, 2004
A molecular epidemiological approach to health risk assessment of urban air pollutionPatrizia Hrelia, Francesca Maffei, Sabrina Angelini, et al.
Pharmacological Research|February 11, 2018
Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysisSarah Cargnin, Gloria Ravegnini, Simona Soverini, et al.
Pharmacogenomics|June 11, 2013
Clinical relevance of pharmacogenetics in gastrointestinal stromal tumor treatment in the era of personalized therapySabrina Angelini, Gloria Ravegnini, Jonathan A Fletcher, et al.
Pageof 10